The Enterprise Value as of November 2025 (TTM) for Zynerba Pharmaceuticals, Inc. (0M40.L) is 19.81M

According to Zynerba Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 19.81M. This represents a change of -185.59% compared to the average of -23151986.14 of the last 4 quarters.

Zynerba Pharmaceuticals, Inc. (0M40.L) Historical Enterprise Value (quarterly & annually)

How has 0M40.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Zynerba Pharmaceuticals, Inc. over the last ten years is 48.75M. The current 19.81M Enterprise Value has changed 3.96% with respect to the historical average. Over the past ten years (40 quarters), 0M40.L's Enterprise Value was at its highest in in the June 2019 quarter at 223.62M. The Enterprise Value was at its lowest in in the December 2022 quarter at -26388729.06.

Zynerba Pharmaceuticals, Inc. (0M40.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Zynerba Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zynerba Pharmaceuticals, Inc. (0M40.L) Average Enterprise Value

How has 0M40.L Enterprise Value performed in the past?

The current Enterprise Value of Zynerba Pharmaceuticals, Inc. (0M40.L) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Zynerba Pharmaceuticals, Inc. (0M40.L) Enterprise Value vs. Peers

How is 0M40.L’s Enterprise Value compared to its peers?

Zynerba Pharmaceuticals, Inc.’s Enterprise Value is less than bluebird bio, Inc. (158.07M), less than MD Medical Group Investments Plc (173.71M), greater than Endo International plc (-939048027.00), greater than Unity Biotechnology, Inc. (18.05M), less than Invitae Corporation (1.50B), less than Palatin Technologies, Inc. (596.99M), greater than Cara Therapeutics, Inc. (18.02M), less than Accelerate Diagnostics, Inc. (52.34M), less than Imunon, Inc. (1.11B), greater than VivoSim Labs, Inc. (-2182528.00),

Build a custom stock screener for Zynerba Pharmaceuticals, Inc. (0M40.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zynerba Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zynerba Pharmaceuticals, Inc. (0M40.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zynerba Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.